--- title: Case Study Rusconi description: Discover how the Rusconi Benessere center, specialists in the treatment of adhesive capsulitis of the shoulder, increased patient adherence by up to 75%. --- [![White Logo ReHub by Dycare](https://www.telerehub.com/hs-fs/hubfs/Dise%C3%B1o%20sin%20t%C3%ADtulo%20(6)-1.png?width=700&height=350&name=Dise%C3%B1o%20sin%20t%C3%ADtulo%20(6)-1.png)](https://www.telerehub.com/?hsLang=en) [![RehubbyDycare_cobalto](https://www.telerehub.com/hs-fs/hubfs/RehubbyDycare_cobalto%20(4).png?width=1092&height=497&name=RehubbyDycare_cobalto%20(4).png) White Logo ReHub by Dycare](https://www.telerehub.com/?hsLang=en) - [Technology](https://www.telerehub.com/en/technology) - [Plans](https://www.telerehub.com/en/pricing) - Solutions - [Insurance](https://www.telerehub.com/en/telerehabilitation-for-insurance) - [Hospitals](https://www.telerehub.com/en/telerehabilitation-for-hospitals) - [Request Demo](https://www.telerehub.com/en/request-demo) - [English](https://www.telerehub.com/en/case-study-rusconi) - [Español](https://www.telerehub.com/es/caso-de-exito-rusconi) - [Italiano](https://www.telerehub.com/it/case-study-rusconi) Search EN       # **Rusconi Benessere** Located between the Italian Alps and the city of Milan, the Rusconi Benessere Center is the most renowned and famous physiotherapy center in Europe for the treatment of adhesive capsulitis of the shoulder. ![rusconi logo 2](https://24887444.fs1.hubspotusercontent-eu1.net/hub/24887444/hubfs/rusconi%20logo%202.jpg?width=150&height=161&name=rusconi%20logo%202.jpg "rusconi logo 2") ### **Challenge** Most patients with adhesive capsulitis recover with nonsurgical treatments, including therapeutic exercise programs. Of course, the degree of clinical improvement depends on the patient's adherence to the program. The problem is that the rehabilitation treatments for adhesive capsulitis in a center are quite expensive in both cost and time, but at the same time the exercise programs carried out by patients at home, without the supervision of the physiotherapist, are usually associated with low adherence. The goal of the Rusconi Benessere Center was to find a balance between both options to achieve the best therapeutic effectiveness and a methodology that would reduce the number of sessions in the center but would motivate patients to exercise at home to achieve a faster recovery. ### **Solution** Rusconi Benessere implemented ReHub as a digital solution for home-based rehabilitation to optimize its treatment services for adhesive capsulitis of the shoulder. After rethinking their approach, they hypothesized that they could reduce from 3 face-to-face sessions per week to 1 face-to-face session every 2 weeks combining 5 sessions per week of autonomous exercise at home. 67 % improvement for patients 80 % satisfaction rate 75 % treatment completed ### **Results** The effect of remote sessions for home rehabilitation with ReHub over a 4-week period was analyzed. These were the results: - 67% improvement among patients who followed the combined rehabilitation therapy, well ahead of 23% who followed the traditional therapy - 75% of patients completed the treatment - 80% satisfaction rate among patients Currently, Rusconi Benessere incorporated ReHub not only for the treatment of shoulder pathologies but also for the treatment of other areas such as the spine and knee. > “I have chosen ReHub for its therapeutic efficacy and because it is safe and professional. Patients have enthusiastically accepted this method not only because they can continue their rehabilitation process but also because they feel they are cared for, thanks to the constant supervision and communication that I provide through ReHub " **Roberta Vaj Physiotherapist and Director** ## Read more case studies [![dkv_Seguros medicos](https://24887444.fs1.hubspotusercontent-eu1.net/hubfs/24887444/dkv_Seguros%20medicos.jpg)](https://www.telerehub.com/en/case-study-dkv?hsLang=en) #### **Health Insurance Company ** Find out how DKV improves the insured's experience by offering a new healthcare service throughout its centers. [Read the full story](https://www.telerehub.com/en/case-study-dkv?hsLang=en) [![CSI caso de estudio](https://24887444.fs1.hubspotusercontent-eu1.net/hubfs/24887444/CSI%20caso%20de%20estudio.jpg)](https://www.telerehub.com/en/case-study-csi?hsLang=en) #### **Public Healthcare** The Consorci Sanitari Integral (CSI) implemented ReHub in less than 2 weeks, increasing the motivation and autonomy of patients during their treatment. [Read the full story](https://www.telerehub.com/en/case-study-csi?hsLang=en) [![ReHub_dycare-white](https://f.hubspotusercontent-eu1.net/hubfs/24887444/Logos%20ReHub/ReHub_dycare-white.png)](https://www.telerehub.com/?hsLang=en) Avda. Meridiana 354 08027 Barcelona **[+34 935 520 029](tel:+34935520029)** [www.dycare.com](http://www.dycare.com)   [twitter](https://twitter.com/DyCareSolutions) [facebook-f](https://www.facebook.com/DyCareSolutions/) [linkedin-in](https://www.linkedin.com/company/dycare/) [youtube](https://www.youtube.com/channel/UC3lCgpp0V3-333dhmUuCwDg) #### **Product** [What is ReHub for?](https://www.telerehub.com/en/home?hsLang=en) [ReHub Technology](https://www.telerehub.com/en/technology?hsLang=en) [Free Trial](https://www.telerehub.com/en/rehub-free-trial?hsLang=en) [Request Demo](https://www.telerehub.com/en/request-demo?hsLang=en) [Pricing](https://www.telerehub.com/en/pricing?hsLang=en) #### **Resources** [Success Stories](https://www.telerehub.com/en/resources?hsLang=en) [Frequent questions](https://www.telerehub.com/en/faq?hsLang=en) [Blog ](https://www.telerehub.com/en/blog?hsLang=en) [Rehub General Conditions of Use](https://www.telerehub.com/en/terms-and-conditions?hsLang=en) [Rehub Privacy Policy](https://www.telerehub.com/en/privacy-policy-rehub?hsLang=en) #### Subscribe to our Monthly Newsletter © 2026 Bio-sensing Solutions SL. All rights reserved - [Privacy Policy](https://www.dycare.com/politica-de-proteccion-de-datos/?lang=en) - [Cookies Policy](https://www.dycare.com/cookies-policy/?lang=en) ![](https://px.ads.linkedin.com/collect/?pid=4210113&fmt=gif)